These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 23637915)
21. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis. Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212 [TBL] [Abstract][Full Text] [Related]
22. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Tanaka M; Matsushita T; Tateishi T; Ochi H; Kawano Y; Mei FJ; Minohara M; Murai H; Kira JI Neurology; 2008 Sep; 71(13):974-81. PubMed ID: 18809833 [TBL] [Abstract][Full Text] [Related]
23. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid. Mellergård J; Edström M; Vrethem M; Ernerudh J; Dahle C Mult Scler; 2010 Feb; 16(2):208-17. PubMed ID: 20007431 [TBL] [Abstract][Full Text] [Related]
24. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases. Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641 [TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder. Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585 [TBL] [Abstract][Full Text] [Related]
26. Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study. Michael BD; Elsone L; Griffiths MJ; Faragher B; Borrow R; Solomon T; Jacob A Cytokine; 2013 Oct; 64(1):90-6. PubMed ID: 23941778 [TBL] [Abstract][Full Text] [Related]
27. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675 [TBL] [Abstract][Full Text] [Related]
28. Increased soluble C5b-9 in CSF of neuromyelitis optica. Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854 [TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica. Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953 [TBL] [Abstract][Full Text] [Related]
30. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal analysis of cytokines and chemokines in the cerebrospinal fluid of a patient with Neuro-Sweet disease presenting with recurrent encephalomeningitis. Kimura A; Sakurai T; Koumura A; Suzuki Y; Tanaka Y; Hozumi I; Nakajima H; Ichiyama T; Inuzuka T Intern Med; 2008; 47(3):135-41. PubMed ID: 18239321 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica. Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Sawai S; Kuwabara S Clin Chim Acta; 2017 Jun; 469():144-149. PubMed ID: 28283439 [TBL] [Abstract][Full Text] [Related]
35. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica. Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620 [TBL] [Abstract][Full Text] [Related]
37. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048 [TBL] [Abstract][Full Text] [Related]
39. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination. Kothur K; Wienholt L; Tantsis EM; Earl J; Bandodkar S; Prelog K; Tea F; Ramanathan S; Brilot F; Dale RC PLoS One; 2016; 11(2):e0149411. PubMed ID: 26919719 [TBL] [Abstract][Full Text] [Related]
40. Hyper-Reflecting Foci in Multiple Sclerosis Retina Associate With Macrophage/Microglia-Derived Cytokines in Cerebrospinal Fluid. Puthenparampil M; Torresin T; Franciotta S; Marin A; De Napoli F; Mauceri VA; Miante S; Pilotto E; Midena E; Gallo P Front Immunol; 2022; 13():852183. PubMed ID: 35664007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]